Combination treatment for newly diagnosed aplastic anemia
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at how well a standard combination of two medicines, cyclosporine and eltrombopag, works for people newly diagnosed with aplastic anemia (a condition where the bone marrow doesn't make enough blood cells). It aims to see if this treatment helps improve blood counts and overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have been newly diagnosed with aplastic anemia (bone marrow aplasia).
- You are starting or have just started treatment with cyclosporine (CSA) and eltrombopag.
- Your general health is good (able to do light activity and care for yourself).
- You do not have a known cause for the aplastic anemia (like inherited or secondary causes).
- You do not have serious heart, lung, liver, kidney problems, a history of cancer, or blood clots, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of drugs to help your bone marrow make more blood cells if you have aplastic anemia and cannot have a stem cell transplant or standard immune therapy. It might improve blood counts and reduce the need for transfusions.
This trial tests whether a new combination of medicines can help treat severe aplastic anemia (SAA) or a related type (TD-NSAA). It uses a drug that helps your body make more platelets, along with immunosuppressants, and may offer an alternative if a bone marrow transplant isn't possible.
This Phase 2 study tests whether starting two oral medicines early—cyclosporine and eltrombopag—can improve severe aplastic anemia in people who have not had prior treatment for it. It may help your blood counts recover without needing stronger or earlier treatments.
This study tests a new pill called avatrombopag to see if it can help increase the number of platelets (cells that help blood clot) in adults with aplastic anemia who have not improved with standard treatments. It may be an option if your disease is hard to treat.
This study tests an experimental treatment made from special immune cells designed to help your body fight aplastic anemia. It may be an option if you still need blood transfusions despite standard treatments.
This trial tests a lower dose of the chemotherapy drug cyclophosphamide combined with standard immune-suppressing medicines for people with newly diagnosed severe aplastic anemia. The goal is to see if this approach works as well as the usual treatment but with fewer side effects.
Hear when a new Aplastic Anemia Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.